<?xml version="1.0" encoding="UTF-8"?>
<supplementary-material content-type="local-data" id="figS2">
 <object-id pub-id-type="doi">10.1128/mBio.02494-19.2</object-id>
 <label>FIG S2</label>
 <p>Detection of cross-reactive antibodies against JEV and YFV in sera of YFV-17D-infected and JE-CVax-vaccinated mice. AG129 mice were prebled before either infection with 10
  <sup>3</sup> PFU of YFV-17D or vaccination with 10
  <sup>4</sup> PFU of JE-CVax/Ixiaro and bled again either at the onset of sickness (YFV-17D) or at 28 dpv (JE-CVax). Preserum (A), serum of YFV-17D infected mice (B), serum of JE-CVax-vaccinated mice (C), and serum of Ixiaro-vaccinated mice (D) were analyzed by both JEV (top) and YFV (bottom) indirect immunofluorescence assay (IIFA; Euroimmun) at a magnification of ×20. Download 
  <inline-supplementary-material id="fS2" mimetype="image" mime-subtype="jpg" xlink:href="mBio.02494-19-sf002.jpg" content-type="local-data" xmlns:xlink="http://www.w3.org/1999/xlink">FIG S2, JPG file, 0.4 MB</inline-supplementary-material>.
 </p>
 <permissions>
  <copyright-statement>Copyright © 2020 Mishra et al.</copyright-statement>
  <copyright-year>2020</copyright-year>
  <copyright-holder>Mishra et al.</copyright-holder>
  <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xmlns:xlink="http://www.w3.org/1999/xlink">
   <license-p>This content is distributed under the terms of the 
    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.
   </license-p>
  </license>
 </permissions>
</supplementary-material>
